Houlihan Lokey Advises White Bridge Investments

Houlihan Lokey is pleased to announce that White Bridge Investments II S.p.A. (White Bridge) has acquired a controlling stake in Delta Med S.p.A., a leading Italian player in the vascular access market, from Augens Capital and Deutsche Bank Private Equity. The transaction closed on 11 October 2021.

Founded in 2013, White Bridge is an Italy-based holding company investing in small and medium Italian enterprises, with a leading position and a strong track record, having completed several transactions across different industries in the last years.

Founded in 1993 and based in Viadana, Mantua, Italy, Delta Med is engaged in the manufacturing of high-quality medical devices with a comprehensive vascular access products portfolio. Main product categories include (i) peripheral intravenous catheters, (ii) critical care catheters (providing access to the central venous system), (iii) other vascular access devices for urodynamics, dialysis, and gynaecology, and (iv) operating room devices (operating room disposables such as surgical drapes, gowns, and other accessories).

Delta Med, through its international network, sells its products in more than 60 countries, with export accounting for approximately 50% of total sales. The company operates through three well-invested manufacturing plants located in northern Italy and employs over 100 people.

Augens Capital and the management of Delta Med have reinvested alongside White Bridge.

Houlihan Lokey served as the exclusive financial advisor to White Bridge throughout the acquisition and financing process, assisting the client in structuring and negotiating every aspect of the deal. The transaction highlights Houlihan Lokey’s leading global Healthcare and Medical Technology franchises.